Virological characteristics of influenza B virus isolated in mainland China during 2014-2015 influenza surveillance year
Xiyan Li, Yanhui Cheng, Minju Tan, Hejiang Wei, Yu Lan, Jing‐Kai Huang, Ning Xiao, Dayan Wang
Abstract
Xiyan Li, Yanhui Cheng, Minju Tan, Hejiang Wei, Yu Lan, Jing‐Kai Huang, Ning Xiao, Dayan Wang
Abstract
Objective To analyze the epidemiological characteristics of the influenza B virus strains circulating in mainland China during 2014-2015 influenza surveillance year and to study the genetic similarity between them and the vaccine strains. Methods Hemagglutinin inhibition test was performed to analyze the antigenicity of influenza B virus strains isolated in mainland China during 2014-2015 influenza surveillance year. The nucleotide sequences of those virus strains were determined by using Sanger dideoxy sequencing. The phylogenetic trees were constructed based on the genes encoding the hemagglutinin 1 (HA1). The genetic characteristics of the influenza B virus strains were determined by comparing with the current vaccine strains. Results The influenza B virus strains accounted for 29.94% of all influenza virus strains isolated during 2014 to 2015. The influenza B virus strains belonged to Yamagata lineage were more than that belonged to Victoria lineage. Most of the Yamagata lineage virus strains were antigenically similar to the B/Massachusetts/2/2012 vaccine strain (95.1%). Only 48.3% of the prevalent virus strains were antigenically similar to the quadrivalent vaccine strain B/Brisbane/60/2008-like virus, while 100% of the strains were antigenically similar to the representative circulating strain B/Beijing-Haidian/1386/2013 in mainland China. Phylogenetic analysis showed that 19 Yamagata lineage virus strains were BY-HA/BV-NA intra-lineage reassortants. Mutations associated with drug resistance in genes encoding the neuraminidase (NA) were found in 8 Yamagata lineage strains, resulting in reduced drug sensitivity. Conclusion The WHO recommended trivalent influenza vaccine could protect from Yamagata lineage influenza B virus infection during 2014-2015 influenza surveillance year. However, the Victoria lineage influenza B virus strains were not match with the quadrivalent influenza vaccine strain. This study indicated that the antigenic and genetic characteristics of the prevalent influenza virus strains should be investigated in a timely manner for the selection of appropriate vaccine strains in China. Key words: Influenza B virus; Antigenic characteristics; Genetic characteristics
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To analyze the epidemiological characteristics of the influenza B virus strains circulating in mainland China during 2014-2015 influenza surveillance year and to study the genetic similarity between them and the vaccine strains. Methods Hemagglutinin inhibition test was performed to analyze the antigenicity of influenza B virus strains isolated in mainland China during 2014-2015 influenza surveillance year. The nucleotide sequences of those virus strains were determined by using Sanger dideoxy sequencing. The phylogenetic trees were constructed based on the genes encoding the hemagglutinin 1 (HA1). The genetic characteristics of the influenza B virus strains were determined by comparing with the current vaccine strains. Results The influenza B virus strains accounted for 29.94% of all influenza virus strains isolated during 2014 to 2015. The influenza B virus strains belonged to Yamagata lineage were more than that belonged to Victoria lineage. Most of the Yamagata lineage virus strains were antigenically similar to the B/Massachusetts/2/2012 vaccine strain (95.1%). Only 48.3% of the prevalent virus strains were antigenically similar to the quadrivalent vaccine strain B/Brisbane/60/2008-like virus, while 100% of the strains were antigenically similar to the representative circulating strain B/Beijing-Haidian/1386/2013 in mainland China. Phylogenetic analysis showed that 19 Yamagata lineage virus strains were BY-HA/BV-NA intra-lineage reassortants. Mutations associated with drug resistance in genes encoding the neuraminidase (NA) were found in 8 Yamagata lineage strains, resulting in reduced drug sensitivity. Conclusion The WHO recommended trivalent influenza vaccine could protect from Yamagata lineage influenza B virus infection during 2014-2015 influenza surveillance year. However, the Victoria lineage influenza B virus strains were not match with the quadrivalent influenza vaccine strain. This study indicated that the antigenic and genetic characteristics of the prevalent influenza virus strains should be investigated in a timely manner for the selection of appropriate vaccine strains in China. Key words: Influenza B virus; Antigenic characteristics; Genetic characteristics
Key concepts: Virology, Biology, Virus, Hemagglutinin (influenza), Neuraminidase, Lineage (genetic), H5N1 genetic structure, Phylogenetic tree